SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 1st, 2019 • Target Group Inc. • Medicinal chemicals & botanical products • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 24, 2018, by and between Target Group Inc. fka Chess Supersite Corporation, a Delaware corporation, with its address at 55 Administration Road, Unit 8, Vaughan, Ontario, Canada L4K 4G9 (the “Company”), and POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY 11021 (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 31st, 2017 • Chess Supersite Corp • Services-amusement & recreation services • New York
This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of September 15, 2016, by and between CHESS SUPERSITE CORPORATION, a Delaware corporation, with headquarters located at 1131A Leslie Street, Suite 101, Toronto, Ontario, Canada M3C 3L8 (the “Company”), and CROWN BRIDGE PARTNERS, LLC, a New York limited liability company, with its address at 1173a 2nd Avenue, Suite 126, New York, NY 10065 (the “Buyer”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 13th, 2017 • Chess Supersite Corp • Services-amusement & recreation services • New York
This SECURITIES PURCHASE AGREEMENT (the "Agreement"), dated as of October 18, 2016 by and between Chess Supersite Corp., a Delaware corporation, with headquarters located at 1131A Leslie Street,, Toronto, Canada ONT M3C 3L8 (the "Company"), and Blackbridge Capital Growth Fund, LLC, a Delaware limited liability company, with its address at 450 7th Ave, Suite 609 New York, NY 10123 (the "Buyer").
CONFIDENTIAL - Licensed Producer / Licensed Processor Sales Agency AgreementProcessor Sales Agency Agreement • April 1st, 2019 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
This SALES AGENCY AGREEMENT (“Agreement”) is made and entered into effect as of the December 12th 2018, by and between Target Group Inc., a corporation existing under the laws of Delaware with its principal office and mailing address at 55 Administration Road, Unit 13, Concord, Ontario, L4K4G9, (hereinafter “Brand Owner”), and Cannavolve Inc (Corporation #1056814-7), organized and existing under the laws of the province of Ontario, with its principal office and mailing address at 293 Laird Avenue, Toronto, Ontario, M4G 3X6, (hereinafter called “The Agent”)
EIGHTH AMENDING AGREEMENTEighth Amending Agreement • May 8th, 2023 • Target Group Inc. • Medicinal chemicals & botanical products
(hereinafter referred to as “Cannakorp”, which together with Visava and Canary shall be collectively referred to as the “Subsidiaries”)
FOURTH AMENDING AND EXTENDING AGREEMENTFourth Amending and Extending Agreement • August 6th, 2021 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
(hereinafter referred to as “Cannakorp”, which together with Visava and Canary shall be collectively referred to as the “Subsidiaries”)
AGREEMENT AND PLAN OF SHARE EXCHANGEAgreement and Plan of Share Exchange • January 29th, 2019 • Target Group Inc. • Medicinal chemicals & botanical products • Delaware
THIS AGREEMENT AND PLAN OF SHARE EXCHANGE (“Agreement”) is dated as of January 25, 2019, and is by and among Target Group Inc., a Delaware corporation (“Company”), CannaKorp, a Delaware corporation (“CannaKorp”), David Manly, solely in his capacity as the Stockholder Representative hereunder, and those CannaKorp Stockholders (as such term is defined below) that elect to execute a joinder agreement hereto and thereby become parties to this Agreement in accordance with its terms (such CannaKorp Stockholders, collectively the “Exchanging Stockholders” and each individually an “Exchanging Stockholder”).
DISTRIBUTION, COLLABORATION AND LICENCING AGREEMENTDistribution, Collaboration and Licencing Agreement • April 1st, 2019 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
Canary Rx Inc., incorporated under the laws of the Province of Ontario and having its registered office at 385 Second Avenue West, Simcoe, On, CANADA
AGREEMENTAgreement • April 14th, 2020 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
AMENDMENT TO DEBT PURCHASE AND ASSIGNMENT AGREEMENT DATED JUNE 15, 2020Debt Purchase and Assignment Agreement • August 18th, 2020 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
This AMENDMENT (“Amendment”) is effective as of August 14, 2020 by and between Target Group Inc., a Delaware corporation (“Target”), Visava Inc., (“Visava”), CanaryRx Inc., (“Canary”), CannaKorp Inc,, a Delaware corporation (“CannaKorp”) , CL Investors Inc. (“CLI”) and Rubin Schindermann (“Schindermann”). Visava, Canary and CL, respectively, are corporations organized under the laws of the Province of Ontario, Canada. Target, Visava, Canary, CannaKorp, CLI and Schindermann are sometimes referred to herein collectively as the “Parties” and individually as a “Party”.
FIRST AMENDING AGREEMENTFirst Amending Agreement • June 5th, 2020 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
JOINT VENTURE OPERATIONS AGREEMENTJoint Venture Operations Agreement • August 10th, 2020 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
SEVENTH AMENDING AGREEMENTSeventh Amending Agreement • May 8th, 2023 • Target Group Inc. • Medicinal chemicals & botanical products
(hereinafter referred to as “Cannakorp”, which together with Visava and Canary shall be collectively referred to as the “Subsidiaries”)
SECOND AMENDING AGREEMENTSecond Amending Agreement • August 10th, 2020 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
DEBT PURCHASE AND ASSIGNMENT AGREEMENTDebt Purchase and Assignment Agreement • August 18th, 2020 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
This DEBT PURCHASE AND ASSIGNMENT AGREEMENT (“Agreement”) is effective as of June 15, 2020 by and between Target Group Inc., a Delaware corporation (“Target”), Visava Inc., (“Visava”), CanaryRx Inc., (“Canary”), CannaKorp Inc,, a Delaware corporation (“CannaKorp”) and CL Investors Inc. (“CLI”). Visava, Canary and CLI, respectively, are corporations organized under the laws of the Province of Ontario, Canada. Target, Visava, Canary, CannaKorp and CLI are sometimes referred to herein collectively as the “Parties” and individually as a “Party”.
Purchase, Licensing and Distribution AgreementPurchase, Licensing and Distribution Agreement • September 19th, 2019 • Target Group Inc. • Medicinal chemicals & botanical products • Arizona
This Purchase, Licensing and Distribution Agreement (including all exhibits attached hereto, this “Agreement”) is made as of September 17th, 2019 (the “Effective Date”), by and between CannaKorp, Inc., a Delaware corporation (“CannaKorp” or “Licensor”), with its principal executive office located at 74 Maple Street, Unit C, Stoneham, Massachusetts 02180, and Nabis Arizona Property LLC or its assignee/designee (“Licensee”), with its principal executive office located at 8925 East Pima Center Parkway, Suite 100, Scotsdale, AZ 85258.
SIXTH AMENDING AGREEMENTSixth Amending Agreement • November 7th, 2022 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
(hereinafter referred to as “Cannakorp”, which together with Visava and Canary shall be collectively referred to as the “Subsidiaries”)
FOURTH AMENDING AND EXTENDING AGREEMENTFourth Amending and Extending Agreement • November 7th, 2022 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
(hereinafter referred to as “Cannakorp”, which together with Visava and Canary shall be collectively referred to as the “Subsidiaries”)
TENTH AMENDING AGREEMENTTenth Amending Agreement • November 7th, 2024 • Target Group Inc. • Medicinal chemicals & botanical products
JERRY ZARCONE (hereinafter referred to as “Jerry”) - and – TARGET GROUP INC. (hereinafter referred to as “TGI”) - and – CANARY RX INC. (hereinafter referred to as “Canary”) - and – VISAVA INC. (hereinafter referred to as “Visava”) - and – CANNAKORP INC. (hereinafter referred to as “Cannakorp”, which together with Visava and Canary shall be collectively referred to as the “Subsidiaries”)
THIRD AMENDING AGREEMENTThird Amending Agreement • August 10th, 2020 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
AGREEMENT AND PLAN OF SHARE EXCHANGEAgreement and Plan of Share Exchange • July 3rd, 2018 • Chess Supersite Corp • Services-amusement & recreation services • Ontario
THIS AGREEMENT AND PLAN OF SHARE EXCHANGE (“Agreement”) is dated as of June 27, 2018, and is by and among Chess Supersite Corporation, a Delaware corporation (“Company”), Visava Inc., an Ontario, Canada corporation (“Visava”) and the undersigned shareholders of Visava (“Visava Shareholders”).
NINTH AMENDING AGREEMENTNinth Amending Agreement • November 8th, 2023 • Target Group Inc. • Medicinal chemicals & botanical products
Ontario, Toronto, July 10, 2018Target Group Inc. • July 10th, 2018 • Services-amusement & recreation services
Effective June 27, 2018, Target Group Inc. (CDBY) (the Company” entered into an Agreement and Plan of Share Exchange (“Exchange Agreement”) with Visava Inc., a private Ontario, Canada corporation (“Visava”). Visava owns 100% of Canary Rx Inc., a Canadian corporation that is the late stage ACMPR applicant with Health Canada. Canary Rx Inc. holds a leasehold interest in a 40,000 sq. ft. parcel of property located in Ontario’s Garden Norfolk County for the production of approximately 3,600,000 gr. of cannabis per year with a focus on producing curated cannabis products. On June 27, 2018, Canary Rx Inc. received a letter of readiness from Health Canada and will finish the buildout of the 40,000 sq. ft. facility within the next 90-120 days.
Management Employment AgreementManagement Employment Agreement • June 19th, 2019 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
WHEREAS the Employer and the Employee are desirous of setting out the terms and conditions of their employment relationship:
PAYOUT AGREEMENTPayout Agreement • May 9th, 2022 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
FIFTH AMENDING AGREEMENTFifth Amending Agreement • November 7th, 2022 • Target Group Inc. • Medicinal chemicals & botanical products • Ontario
(hereinafter referred to as “Cannakorp”, which together with Visava and Canary shall be collectively referred to as the “Subsidiaries”)
SEVENTH AMENDING AGREEMENTSeventh Amending Agreement • August 9th, 2023 • Target Group Inc. • Medicinal chemicals & botanical products
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • August 13th, 2019 • Target Group Inc. • Medicinal chemicals & botanical products • California
This exclusive license agreement (“Agreement”) is made effective this 8th day of August, 2019 (“Effective Date”), by and between cGreen, Inc., a corporation having its principal place of business at 10 E Yanonali Street #134, Santa Barbara, CA 93101(“Licensor”) and Target Group Inc., a Delaware corporation having its principal place of business at 13-55 Administration Road, Unit 13, Vaughan, ON L4K 4G9 (the “Licensee”) Licensee and Licensor are hereafter referred individually as a “Party” or “party”, and collectively as the “Parties” or “parties”.
